George Washington University
Also known as: Ali Ramezani | Alison Ehrlich | Biostatistical Coordinating Center - George Washington Univ. | Campbell Grant | Children's Hospital National Medical Center | Dominic Raj | Georege Washington University | George Washigton University | George Washington Cancer Center | George Washington University | George Washington University Biostatistics Center | George Washington University; Childrens National Medical Center | George Washington University CRS | George Washington University Department of Dermatology | George Washington University Medical Faculty Associates | George Washington University School of Medicine | George Washington University School of Medicine and Health Sciences | George Washington University School of Medicine & Health Sciences | George Washington University School of Public Health | GWU | GWUMC Medical Faculty Associates | GWU Medical Faculty | Homa Ahmadzia | Khashayar Vaziri | Mardi Gomberg -Maitland | Media Rez | Sabyasachi Sen | The George Washington University | The George Washington University Biostatistics Center | The George Washington University Medical Faculty Associates | Vivek Jain
Highest phase reached
Phase 4
First clinical trial
Jun 1, 1973Last known activity
Nov 30, 2025
Timeline
1820s
- Jul 1, 1821
George Washington University— Founded
Drugs by trial phase (141 distinct, 122 trials)
Phase 4 (37 own, 0 via acquisition)
Phase 3 (35 own, 0 via acquisition)
Phase 2 (41 own, 0 via acquisition)
Phase 1 (21 own, 0 via acquisition)
Other trials (7 own, 0 via acquisition)
Indications
Studied for
- Abruptio Placentae
- Acquired Immunodeficiency Syndrome
- Acute Pain
- Adenocarcinoma
- Alcoholism
- Alzheimer Disease
- Ancylostomiasis
- Anemia, Neonatal
- Anemia, Sickle Cell
- Anxiety Disorders
- Apnea
- Arteriosclerosis
- Arthritis
- Atherosclerosis
- Back Pain
- Birth Weight
- Body Weight
- Bronchopulmonary Dysplasia
- Burkitt Lymphoma
- Calcinosis
- Carcinoid Tumor
- Carcinoma, Ovarian Epithelial
- Cardiovascular Diseases
- Cerebral Palsy
- Chikungunya Fever
- Colorectal Neoplasms
- Communicable Diseases
- Coronary Artery Disease
- Coronary Disease
- Cytomegalovirus Infections
- Deficiency Diseases
- Delirium
- Dengue
- Dermatitis
- Dermatomyositis
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Dysbiosis
- Emergencies
- Facial Pain
- Fractures, Bone
- Fractures, Multiple
- Gastrointestinal Neoplasms
- Head and Neck Neoplasms
- Heart Diseases
- Hematologic Diseases
- Hemoglobinopathies
- Hemorrhage
- Hernia
- Hernia, Abdominal
- HIV Infections
- Hookworm Infections
- Hypercholesterolemia
- Hyperkalemia
- Hyperplasia
- Hypertension
- Hypertension, Pregnancy-Induced
- Hypertension, Pulmonary
- Hypertrophy
- Hypotension
- Hypothyroidism
- Immunologic Deficiency Syndromes
- Infarction
- Infections
- Inflammation
- Influenza, Human
- Intracranial Hemorrhages
- Ischemia
- Kidney Diseases
- Kidney Failure, Chronic
- Leukemia
- Leukomalacia, Periventricular
- Lymphoma
- Lymphoma, B-Cell
- Malignant Carcinoid Syndrome
- Mental Disorders
- Muscle Weakness
- Myasthenia Gravis
- Myocardial Infarction
- Myocardial Ischemia
- Neck Pain
- Nematode Infections
- Neuralgia
- Neuralgia, Postherpetic
- Obstetric Labor Complications
- Ovarian Neoplasms
- Persistent Fetal Circulation Syndrome
- Phobia, Social
- Pneumonia
- Pneumonia, Aspiration
- Pneumonia, Pneumocystis
- Postoperative Pain
- Postpartum Hemorrhage
- Pre-Eclampsia
- Pregnancy Complications
- Premature Birth
- Prostatic Hyperplasia
- Prostatic Neoplasms
- Psychomotor Agitation
- Psychotic Disorders
Recent trials (50)
- NCT06948825OfficialPhase 2Nov 30, 2025
- NCT06948825Lead sponsorPhase 2Nov 30, 2025
- NCT07102940Lead sponsorPhase 2Nov 1, 2025
- NCT07102940Sponsor investigatorPhase 2Nov 1, 2025
- NCT06069856Lead sponsorPhase 3Sep 30, 2025
- NCT06069856OfficialPhase 3Sep 30, 2025
- NCT06792500Lead sponsorPhase 1/Phase 2Sep 30, 2025
- NCT06069856Overall official - principal investigatorPhase 3Sep 30, 2025
- NCT06792500OfficialPhase 1/Phase 2Sep 30, 2025
- NCT06069856Sponsor investigatorPhase 3Sep 30, 2025
- NCT07221019Lead sponsorPhase 4Sep 12, 2025
- NCT06980025Lead sponsorPhase 3Jun 10, 2025
- NCT06980025OfficialPhase 3Jun 10, 2025
- NCT06810375Sponsor investigatorPhase 3Mar 1, 2025
- NCT06810375Lead sponsorPhase 3Mar 1, 2025
Details
- Founded
- Washington, DC, US Jul 1, 1821
- Last known activity
- Nov 30, 2025